Author Correction: Molecular basis of mycobacterial survival in macrophages.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

4 citing papers in PubMed.

1. Multidrug-resistant tuberculosis: a comprehensive review of pathogenesis, drug resistance, current treatment and future prospects.Archives of microbiology · 2026
   Review
2. Nontuberculous Mycobacteria, Macrophages, and Host Innate Immune Response.Infection and immunity · 2021
   Review
3. Early secreted antigenic target of 6-kDa of Mycobacterium tuberculosis promotes caspase-9/caspase-3-mediated apoptosis in macrophages.Molecular and cellular biochemistry · 2019
   Article
4. Polymorphism in the EREG gene confers susceptibility to tuberculosis.BMC medical genetics · 2019
   Article

Corrections and comments

• Erratum for
  Molecular basis of mycobacterial survival in macrophages.2017

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract